StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Y-mAbs Therapeutics (YMAB) Announces Dr. Gerard Ber to Board, Succeeding Dr. Michael Buschle
December 11, 2018 5:09 PM
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) today announced the appointment of the molecular nuclear medicine executive, Dr. Gérard Ber, PhD to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Management Changes
Management Comments
Next Articles
Y-mAbs Announces Appointment of Gérard Ber to its Board of Directors and Planned Departure of Michael Buschle
December 11, 2018 5:03 PM
Pre-Open Movers 12/11: (YMAB) (ENTX) (GPS) Higher; (OPK) (SFIX) (CAMP) Lower (more...)
December 11, 2018 9:29 AM
Y-mAbs Therapeutics (YMAB) Reports FDA Clearance of IND for Bispecific GD2 Antibody
December 10, 2018 5:40 PM
